EFPIA - NEWSLETTER

Trouble reading this email? View it in your browser


		EFPIA Newsletter 21 September 2017

#WeWontRest video

Blogs

21092017 ISENTRESS: integrase strand transfer inhibitor active against HIV type 1
21 September 2017

With over 7000 medicines in development, new treatments will continue to change patients’ lives; slowing disease progression,... Read more

21092017 Disease interception – What does it mean and why is it important? (Guest blog)
21 September 2017 - Paul McCleverty

As our scientific understanding increases, catching diseases earlier is becoming more and more likely. For many conditions,... Read more

Events

15 June 2017 First edition of the ‘Real-World Evidence in Medicine Development’ course by GetReal...
02 October 2017 (Online learning)

A course by GetReal Read more

11 September 2017 2017 ICHOM Conference
25 October 2017 (Washington, D.C.)

Join value-innovators from across the health care spectrum in Washington, D.C. Read more

19 July 2017 War on Cancer – a patient’s journey
21 November 2017 (The HAC, London, UK)

3rd annual conference organised by The Economist Events Read more

What we are reading

World needs vigorous regulatory action to fight AMR
On 01 January 0001 (The Parliament Magazine)

The global response to AMR requries strong collaboration between the environmental, trade, innovation and human and... Read more

About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 37 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55
E-mail:Communications@efpia.eu